An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013)

Ikuto Masakane(Japanese Society for Dialysis Therapy), Kosaku Nitta(Japanese Society for Dialysis Therapy), Kenji Wakai(Japanese Society for Dialysis Therapy), Shigeru Nakai(Japanese Society for Dialysis Therapy), Norio Hanafusa(Tokyo Women's Medical University Hospital), Naoki Kimata(Japanese Society for Dialysis Therapy), Takayuki Hamano(Japanese Society for Dialysis Therapy), Atsushi Wada(Japanese Society for Dialysis Therapy), Satoshi Ogata(Japanese Society for Dialysis Therapy)
Therapeutic Apheresis and Dialysis
December 1, 2015
10.1111/1744-9987.12378
Cited by 425

Related Papers

Common Defects of ABCG2, a High-Capacity Urate Exporter, Cause Gout: A Function-Based Genetic Analysis in a Japanese Population
|Science Translational Medicine|2009|434
Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes
|JAMA|2023|310
Overview of Regular Dialysis Treatment in Japan (as of 31 December 2008)
|Therapeutic Apheresis and Dialysis|2010|228
Overview of Regular Dialysis Treatment in <scp>J</scp>apan (as of 31 <scp>D</scp>ecember 2011)
|Therapeutic Apheresis and Dialysis|2013|198
GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes
|Annals of the Rheumatic Diseases|2016|173